"Why women on (or recently off) birth control can't feel their own libido."

Okay so — imagine two women. Same age bracket, 43 years old. Same complaint: exhausted, zero libido, flat mood, can’t build muscle no matter how hard they train. Their doctors run testosterone panels. Both come back “normal.” One gets told she’s just stressed. The other gets told she’s just entering perimenopause.

Here’s the thing: one of those women is severely testosterone deficient. The other isn’t.

And you’d never know it from their labs — unless you knew exactly what to look for.

This is not a hypothetical. It’s documented in published research (PMC7663738, open access). Two real women. Woman A: total testosterone 50.4 ng/dL, SHBG 28 nmol/L. Woman B: total testosterone 48.9 ng/dL, SHBG 196 nmol/L — nearly 7 times higher. Their total testosterone is nearly identical. But Woman B’s free testosterone — the fraction that actually enters cells and does anything — is 4.4 times lower. She is functionally testosterone deficient while her labs say “normal.”

The difference? Woman B was on the pill.

What SHBG Actually Is (and Why Nobody Explains It)

Sex Hormone-Binding Globulin — SHBG — is a protein your liver produces that acts like a taxi service for hormones. It picks up testosterone (and estrogen) and carries them through your bloodstream. The problem is, hormones riding in the taxi can’t get out and do their job. Only free testosterone — the fraction not bound to SHBG or albumin — can enter your cells, activate receptors, and produce effects.

Think of it this way: total testosterone is how much money is in your bank account. Free testosterone is how much cash you actually have in your wallet. SHBG is what moved everything from your wallet to a locked vault that requires three signatures to open.

When SHBG goes up, free testosterone goes down — not proportionally, but dramatically. SHBG binds testosterone with much higher affinity than it binds estrogen. A modest increase in SHBG can slash free testosterone by 40–60%. A large increase, the kind triggered by oral contraceptive pills, can render a woman’s free testosterone clinically undetectable while her total testosterone reads perfectly fine.

Standard lab panels check total testosterone. Almost no routine perimenopausal workup checks SHBG. This is the diagnostic blindspot that’s leaving a generation of women undiagnosed.

How the Pill Does This

Combined oral contraceptive pills (OCPs) contain two hormones: a synthetic estrogen — almost always ethinyl estradiol — and a progestin. The ethinyl estradiol is the mechanism here. It sends a powerful signal to your liver: produce more SHBG.

And the liver listens.

The average increase? In meta-analysis, around 99 nmol/L — causing roughly a 61% drop in free testosterone (Zimmerman 2013). For reference, a normal SHBG in a premenopausal woman not on the pill is somewhere around 20–60 nmol/L. OCP users routinely run 100–200 nmol/L. That’s not a small perturbation. That’s a systemic reconfiguration.

Now add the progestin variable, because not all pills are equally bad here.

Levonorgestrel-containing pills (many older and generic formulations) are androgenic — meaning the progestin itself has mild testosterone-like activity at androgen receptors. This partially counteracts the SHBG rise from ethinyl estradiol, capping the increase around 50%. Still elevated. But not catastrophic.

Drospirenone-containing pills — Yaz, Yasmin, Beyaz, and their generics — are a different story. Drospirenone is derived from spironolactone, which is an anti-androgen. It doesn’t just fail to counteract the SHBG rise. It actively blocks testosterone at the receptor level. So you get maximum SHBG elevation from the ethinyl estradiol and direct anti-androgenic activity from the progestin. Double suppression.

Desogestrel- and gestodene-containing pills (third-generation formulations common in Europe) cause SHBG increases of 200–300% above baseline. That is not a typo.

It Doesn’t Go Away When You Stop

Here’s where this gets genuinely alarming, and where the medical literature has been too quiet.

Most women and most doctors assume: stop the pill, hormones normalize. Give it a couple weeks. You’ll be fine.

That is not what the research shows.

The Panzer et al. 2006 study in the Journal of Sexual Medicine followed 124 premenopausal women with sexual health complaints — current OCP users, women who had recently stopped, and women who had never used OCPs. What they found: SHBG in current users was four times higher than in never-users. When women stopped the pill, SHBG did begin to fall. But it did not return to never-user levels — not at 80 days post-pill, not at 196 days post-pill. Six and a half months after stopping, SHBG remained significantly elevated compared to women who had never taken the pill.

The researchers’ conclusion: “SHBG values may remain elevated to values significantly higher than ‘never users’ for a prolonged period of time despite discontinuation of oral contraceptives.”

Why? Because the liver, after years of synthetic estrogen exposure, adapts. It recalibrates its baseline SHBG output upward. The stimulus is gone, but the liver’s new normal takes time to reset — and for long-term users (we’re talking 10, 15, 20 years on the pill), that reset may take 12 months or longer. The data is sparse because this hasn’t been studied nearly enough.

The Perimenopause Timing Trap

Now here’s where this becomes a generation-level problem.

Women’s testosterone doesn’t crash at menopause. It declines continuously from the mid-20s — roughly 50% by age 40, before most women have a single hot flash or missed period. The testosterone graph isn’t a cliff at menopause; it’s a long, steady slope downward across the entire reproductive lifespan.

Women who took OCPs from age 22 to age 42 — which describes millions of women who used the pill for contraception through their peak reproductive years — arrive at perimenopause already carrying two hormonal burdens:

Their naturally declining testosterone is already at 50–60% of what it was at 25.
Their liver is still overproducing SHBG from two decades of ethinyl estradiol stimulation.

When they stop the pill — often because they’re done with contraception, or because their prescriber finally offers alternatives — they don’t step gracefully out of the pill’s hormonal influence. They step off a cliff into a period where:

Total testosterone is declining from an age-related baseline that’s already half of peak
SHBG remains elevated from years of pill use, binding a larger fraction of that reduced total
Perimenopausal fluctuating estrogen further drives SHBG variability
Free testosterone may hit near-zero while total testosterone looks “technically normal”

And the symptoms of this combined crash — low libido, fatigue, brain fog, flat mood, inability to build muscle, reduced motivation — are indistinguishable from perimenopause itself. So they get told: “You’re in perimenopause. This is normal.”

Which is true. And completely misleading.

The Diagnosis Being Missed in Millions of Exams

Let me be specific about what’s happening in exam rooms every day.

A perimenopausal woman presents with classic low testosterone symptoms. Her doctor runs a testosterone panel. “Total testosterone: 42 ng/dL — normal range for women.” She’s told her testosterone is fine.

Nobody runs SHBG. Nobody runs free testosterone. The total testosterone number is real, technically accurate, and essentially useless for understanding whether she has sufficient bioavailable testosterone.

The correct workup: total testosterone + free testosterone by equilibrium dialysis + SHBG. Equilibrium dialysis is the gold standard for measuring free testosterone — other methods (calculated free T, direct immunoassay) introduce significant error at the low concentrations found in women. Order all three. Draw in the morning when testosterone peaks.

Most primary care doctors don’t order this panel. Many OB/GYNs don’t either, unless they’ve specifically trained in menopause medicine. Women who find answers are typically the ones who’ve done enough reading to walk in and ask for it by name — and then find a provider who won’t dismiss the request.

What to Do If This Is You

If you’ve been on combined oral contraceptive pills for more than a few years and you stopped within the last 12–18 months — or if you’re currently on OCPs and approaching your 40s — this is worth a conversation with your prescriber. Here’s what to ask:

The lab request: “Can we run a complete hormonal panel including total testosterone, free testosterone by equilibrium dialysis, and SHBG? I’ve read that OCP use can suppress free testosterone through SHBG elevation and I’d like a full picture.”

If you’re still on OCPs and still need contraception: Not all options raise SHBG equivalently. The Mirena IUD (levonorgestrel-containing, local delivery) does not significantly elevate SHBG. Progestin-only pills have a smaller SHBG effect than combined pills. These are conversations worth having.

If you stop the pill and feel worse than expected: This isn’t in your head. The post-pill SHBG elevation is real, documented, and may persist for months. If your free testosterone comes back low and your SHBG is still elevated 6–12 months post-pill, that’s data — not a mystery.

If free testosterone comes back low relative to SHBG: The treatment conversation is nuanced — low-dose testosterone therapy for women is supported by NAMS and ISSSWSH clinical guidelines for hypoactive sexual desire disorder, though guidelines for broader symptoms are still evolving. Find a menopause specialist or a provider trained through NAMS or ISSWSH for this conversation, not a general practitioner who’s never ordered free T for a woman.

The Closing Thought

How many women are right now walking through their lives carrying the hormonal signature of severe testosterone deficiency — zero drive, zero desire, can’t build muscle, brain in a fog — while their labs read “normal total testosterone” and their doctor reassures them that everything is fine?

We make women feel crazy for noticing. We hand them antidepressants. We tell them it’s stress, or menopause, or just getting older.

Some of it is perimenopause. Some of it is stress. And some of it is that a medication millions of women took faithfully for decades quietly reconfigured their liver’s hormone-binding protein production — and no one ever mentioned that this could happen, that it might persist, or that there was a test that could detect it.

The test takes 10 minutes to order. The information changes what a woman asks for and what her doctor looks for. That’s not a small thing.

Ask for the full panel: total testosterone, free testosterone by equilibrium dialysis, SHBG. Those three numbers together tell a story that one number alone never will.

Sources:

Panzer C et al. (2006). Impact of Oral Contraceptives on Sex Hormone-Binding Globulin and Androgen Levels. Journal of Sexual Medicine, 3(1):104–113. PubMed
Zimmerman Y et al. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1):76–105.
ISSSWSH Clinical Practice Guideline for Systemic Testosterone for HSDD in Women. PMC
NAMS Practice Pearl — Testosterone Use for Hypoactive Sexual Desire Disorder. NAMS/Huntington Health
Choosing a combined oral contraceptive pill. PMC

Annette Thompson is 57, the founder of adoption.com, and a menopause advocate writing about evidence-based women’s health.